Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMC 2756125)

Published in Blood on July 23, 2009

Authors

Yenan T Bryceson1, Hans-Gustaf Ljunggren, Eric O Long

Author Affiliations

1: Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD 20852, USA. yenan.bryceson@ki.se

Articles citing this

Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood (2009) 3.46

Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 3.38

Epithelial decision makers: in search of the 'epimmunome'. Nat Immunol (2010) 2.19

Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe (2010) 1.74

Remodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopy. PLoS Biol (2011) 1.70

Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells. Blood (2014) 1.62

ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc Natl Acad Sci U S A (2011) 1.35

An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation. Sci Transl Med (2011) 1.33

Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells. J Cell Biol (2011) 1.26

Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity (2010) 1.25

XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood (2014) 1.17

Human NK cell lytic granules and regulation of their exocytosis. Front Immunol (2012) 1.10

Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2. Proc Natl Acad Sci U S A (2010) 1.09

Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience. Curr Opin Virol (2011) 1.09

Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A. PLoS One (2012) 1.09

The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity (2012) 1.07

Cell biological steps and checkpoints in accessing NK cell cytotoxicity. Immunol Cell Biol (2014) 1.07

Tethering of intercellular adhesion molecule on target cells is required for LFA-1-dependent NK cell adhesion and granule polarization. J Immunol (2010) 1.04

Natural killer cell responses to viral infection. J Innate Immun (2011) 1.03

Natural killer cells: multifaceted players with key roles in hepatitis C immunity. Immunol Rev (2013) 0.95

Expansion of 2B4+ natural killer (NK) cells and decrease in NKp46+ NK cells in response to influenza. Immunology (2011) 0.94

Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins. Blood (2012) 0.94

Cutting edge: NK cell licensing modulates adhesion to target cells. J Immunol (2013) 0.93

Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds. Blood (2015) 0.93

NK-cell-dependent killing of colon carcinoma cells is mediated by natural cytotoxicity receptors (NCRs) and stimulated by parvovirus infection of target cells. BMC Cancer (2013) 0.91

Roles of Vpr and Vpx in modulating the virus-host cell relationship. Mol Aspects Med (2010) 0.90

Complementary phosphorylation sites in the adaptor protein SLP-76 promote synergistic activation of natural killer cells. Sci Signal (2012) 0.89

Human immunodeficiency syndromes affecting human natural killer cell cytolytic activity. Front Immunol (2014) 0.88

Inhibitory receptor signaling destabilizes immunological synapse formation in primary NK cells. Front Immunol (2013) 0.87

Homotypic cell to cell cross-talk among human natural killer cells reveals differential and overlapping roles of 2B4 and CD2. J Biol Chem (2010) 0.87

Kinome analysis of receptor-induced phosphorylation in human natural killer cells. PLoS One (2012) 0.87

The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation. EMBO Mol Med (2015) 0.86

Structural insights into activation of antiviral NK cell responses. Immunol Rev (2012) 0.85

Innate immune natural killer cells and their role in HIV and SIV infection. HIV Ther (2010) 0.85

Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications. Front Immunol (2015) 0.84

Distinct structural and catalytic roles for Zap70 in formation of the immunological synapse in CTL. Elife (2014) 0.84

Cutting edge: NKG2D-dependent cytotoxicity is controlled by ligand distribution in the target cell membrane. J Immunol (2011) 0.82

TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells. Oncotarget (2015) 0.81

Lytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cells. J Immunol (2010) 0.81

The natural killer cell cytotoxic function is modulated by HIV-1 accessory proteins. Viruses (2011) 0.81

A single amino acid change in inhibitory killer cell Ig-like receptor results in constitutive receptor self-association and phosphorylation. J Immunol (2014) 0.80

NK cells blur the frontier between innate and acquired immunity. Front Immunol (2013) 0.79

NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation. Front Immunol (2015) 0.79

Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency. J Exp Med (2016) 0.78

Signaling for synergistic activation of natural killer cells. Immune Netw (2012) 0.78

Tumor-primed NK cells: waiting for the green light. Front Immunol (2013) 0.77

NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization. Front Immunol (2015) 0.77

Impact of the NK cell receptor LIR-1 (ILT-2/CD85j/LILRB1) on cytotoxicity against multiple myeloma. Clin Dev Immunol (2012) 0.76

Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30. Oncoimmunology (2015) 0.76

Ras-related C3 Botulinum Toxin Substrate (Rac) and Src Family Kinases (SFK) Are Proximal and Essential for Phosphatidylinositol 3-Kinase (PI3K) Activation in Natural Killer (NK) Cell-mediated Direct Cytotoxicity against Cryptococcus neoformans. J Biol Chem (2016) 0.76

Distinct Effects of Dexamethasone on Human Natural Killer Cell Responses Dependent on Cytokines. Front Immunol (2017) 0.75

Granule-Dependent Natural Killer Cell Cytotoxicity to Fungal Pathogens. Front Immunol (2017) 0.75

Generation and preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of natural killer (NK) cells against leukemia. J Biol Chem (2015) 0.75

Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy. Exp Mol Med (2017) 0.75

Protein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector Functions. Front Immunol (2013) 0.75

The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy. Front Immunol (2017) 0.75

Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy. Semin Immunol (2017) 0.75

Articles cited by this

NK cell recognition. Annu Rev Immunol (2005) 14.40

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods (2003) 11.81

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science (1999) 11.04

The biology of human natural killer-cell subsets. Trends Immunol (2001) 10.10

Functions of natural killer cells. Nat Immunol (2008) 9.88

T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature (1989) 9.29

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature (1998) 7.12

MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol (2005) 6.98

Human NK cell education by inhibitory receptors for MHC class I. Immunity (2006) 6.73

Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity (2007) 5.50

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity (2008) 5.35

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood (2005) 3.99

Natural killer cells as an initial defense against pathogens. Curr Opin Immunol (2006) 3.55

Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol (2005) 3.54

Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med (2005) 3.41

Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity (1996) 3.33

Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev (2006) 3.30

Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol (2008) 3.17

A human lymphocyte-associated antigen involved in cell-mediated lympholysis. Eur J Immunol (1983) 3.08

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med (1998) 2.87

Regulated expression of Mg2+ binding epitope on leukocyte integrin alpha subunits. EMBO J (1989) 2.84

Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity (1998) 2.54

Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nat Immunol (2004) 2.40

Negative signaling by inhibitory receptors: the NK cell paradigm. Immunol Rev (2008) 2.40

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol (1997) 2.36

NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat Immunol (2003) 2.33

Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood (2007) 2.32

The primacy of affinity over clustering in regulation of adhesiveness of the integrin {alpha}L{beta}2. J Cell Biol (2004) 2.22

T-cell integrins: more than just sticking points. J Cell Sci (2003) 2.21

Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol (2008) 2.15

Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol (2003) 2.15

Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J Exp Med (1993) 2.13

Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity (2008) 2.03

Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J Immunol (1988) 2.00

LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol (2004) 2.00

Surface NK receptors and their ligands on tumor cells. Semin Immunol (2006) 1.92

Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J Immunol (1996) 1.90

Arousal and inhibition of human NK cells. Immunol Rev (1997) 1.87

Analysis of natural killer-cell function in familial hemophagocytic lymphohistiocytosis (FHL): defective CD107a surface expression heralds Munc13-4 defect and discriminates between genetic subtypes of the disease. Blood (2006) 1.82

Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells. Proc Natl Acad Sci U S A (1992) 1.79

Vav1 controls integrin clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells. Immunity (2002) 1.77

On the species specificity of the interaction of LFA-1 with intercellular adhesion molecules. J Immunol (1990) 1.59

Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity). Eur J Immunol (1984) 1.48

The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance. Semin Cancer Biol (2006) 1.45

Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med (2003) 1.44

Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr Opin Hematol (2002) 1.43

Small GTPases and LFA-1 reciprocally modulate adhesion and signaling. Immunol Rev (2007) 1.42

CD18 activation epitopes induced by leukocyte activation. J Immunol (2001) 1.34

Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J Immunol (2003) 1.33

NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J Immunol (2000) 1.26

Fc receptors on natural killer cells. Curr Top Microbiol Immunol (1998) 1.25

A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow. Blood (2003) 1.20

Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. J Immunol (1999) 1.10

Protein kinase C is involved in the regulation of both signaling and adhesion mediated by DNAX accessory molecule-1 receptor. J Immunol (1998) 1.07

Proline-rich tyrosine kinase 2 and Rac activation by chemokine and integrin receptors controls NK cell transendothelial migration. J Immunol (2003) 1.02

Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. J Immunol (1998) 1.01

Cancer immunosurveillance: NKG2D breaks cover. Immunity (2008) 0.95

Adhesion in NK cell function. Curr Top Microbiol Immunol (1998) 0.94

Adhesion mediated by LFA-1 is required for efficient IL-12-induced NK and NKT cell cytotoxicity. Eur J Immunol (2000) 0.93

Regulation of integrin activation through the B-cell receptor. J Cell Sci (2008) 0.90

Motility and ultrastructure of large granular lymphocytes on lipid bilayers reconstituted with adhesion receptors LFA-1, ICAM-1, and two isoforms of LFA-3. J Cell Biol (1991) 0.89

Functional characterization of natural killer cells in type I leukocyte adhesion deficiency. Blood (2007) 0.89

CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. J Immunol (1999) 0.88

Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells. Hum Immunol (2000) 0.86

Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase. Biochem J (1996) 0.84

Activating Ly-49 receptors regulate LFA-1-mediated adhesion by NK cells. J Immunol (2007) 0.80

Articles by these authors

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood (2005) 3.99

Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood (2010) 3.58

Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood (2009) 3.46

Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med (2005) 3.41

Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev (2006) 3.30

Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science (2004) 3.08

Heat-shock proteins as activators of the innate immune system. Trends Immunol (2002) 2.96

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med (2010) 2.89

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood (2009) 2.88

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res (2003) 2.44

Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood (2007) 2.32

Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol (2008) 2.15

Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol (2003) 2.15

Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol (2006) 2.08

Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med (2012) 2.08

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood (2013) 2.04

The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J (2006) 2.04

Inhibitory receptor signaling via tyrosine phosphorylation of the adaptor Crk. Immunity (2008) 2.03

LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol (2004) 2.00

Memory CD8+ T cells provide an early source of IFN-gamma. J Immunol (2003) 1.93

KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood (2009) 1.92

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology (2010) 1.85

CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med (2004) 1.80

Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. Immunity (2009) 1.74

Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol (2002) 1.66

Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood (2005) 1.61

KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J Immunol (2002) 1.54

Organ-specific features of natural killer cells. Nat Rev Immunol (2011) 1.48

Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition. J Immunol (2004) 1.46

Cytotoxic immunological synapses. Immunol Rev (2010) 1.45

Understanding how combinations of HLA and KIR genes influence disease. J Exp Med (2005) 1.45

DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells. Cancer Res (2007) 1.45

Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med (2003) 1.44

Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J Exp Med (2003) 1.41

Pillars article: Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 1989. 340: 443-448. J Immunol (2007) 1.40

DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells. Sci Signal (2010) 1.39

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells. J Immunol (2009) 1.38

Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J Immunol (2003) 1.33

NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol (2004) 1.30

CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol (2010) 1.30

Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc Natl Acad Sci U S A (2012) 1.29

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components. Blood (2008) 1.28

Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase. Immunity (2010) 1.25

Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment. J Immunol (2009) 1.24

Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med (2006) 1.17

Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype. J Immunol (2008) 1.17

Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells. Mol Immunol (2005) 1.17

Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity. Blood (2009) 1.16

Functional analysis of human NK cells by flow cytometry. Methods Mol Biol (2010) 1.16

Spontaneous clustering and tyrosine phosphorylation of NK cell inhibitory receptor induced by ligand binding. J Immunol (2003) 1.15

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study. Immunotherapy (2009) 1.14

NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation. Blood (2010) 1.14

Natural killer and dendritic cell contact in lesional atopic dermatitis skin--Malassezia-influenced cell interaction. J Invest Dermatol (2002) 1.12

The crystal structure of the major cat allergen Fel d 1, a member of the secretoglobin family. J Biol Chem (2003) 1.11

Natural killer cells in human autoimmunity. Curr Opin Immunol (2009) 1.11

Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. Blood (2013) 1.11

Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-kappaB inhibition. Proc Natl Acad Sci U S A (2004) 1.11

NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol (2004) 1.11

KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation. Mol Immunol (2005) 1.10

KIR2DL4 (CD158d): An activation receptor for HLA-G. Front Immunol (2012) 1.10

Comment on "Killer Ig-like receptor 2DL4 does not mediate NK Cell IFN-γ responses to soluble HLA-G preparations". J Immunol (2014) 1.09

Longitudinal analysis of the human T cell response during acute hantavirus infection. J Virol (2011) 1.09

The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity (2012) 1.07

2B4/CD48-mediated regulation of lymphocyte activation and function. J Immunol (2005) 1.07

Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets. J Immunol Methods (2007) 1.07

Pillars article: Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity. 1996. 4: 77-85. J Immunol (2013) 1.07

NKG2D performs two functions in invariant NKT cells: direct TCR-independent activation of NK-like cytolysis and co-stimulation of activation by CD1d. Eur J Immunol (2011) 1.05

Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation. Transplantation (2004) 1.05

CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells. Blood (2012) 1.04

Tethering of intercellular adhesion molecule on target cells is required for LFA-1-dependent NK cell adhesion and granule polarization. J Immunol (2010) 1.04

KIR enrichment at the effector-target cell interface is more sensitive than signaling to the strength of ligand binding. Eur J Immunol (2003) 1.03

β2 integrin induces TCRζ-Syk-phospholipase C-γ phosphorylation and paxillin-dependent granule polarization in human NK cells. J Immunol (2011) 1.02

Transmission of Toxoplasma gondii from infected dendritic cells to natural killer cells. Infect Immun (2009) 1.01

Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations. Pediatr Blood Cancer (2010) 1.01

Signal transduction during activation and inhibition of natural killer cells. Curr Protoc Immunol (2010) 1.00

Distinct role of rab27a in granule movement at the plasma membrane and in the cytosol of NK cells. PLoS One (2010) 0.99

Recruitment of activation receptors at inhibitory NK cell immune synapses. PLoS One (2008) 0.99

Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-1 neuronal cells. J Virol (2004) 0.99

Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system. Viral Immunol (2003) 0.98

Cytokine-induced killer T cells kill immature dendritic cells by TCR-independent and perforin-dependent mechanisms. J Leukoc Biol (2006) 0.98

Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes. Nat Immunol (2009) 0.98

Two modes of lytic granule fusion during degranulation by natural killer cells. Immunol Cell Biol (2011) 0.97

Activation of innate immunity, inflammation, and potentiation of DNA vaccination through mammalian expression of the TLR5 agonist flagellin. J Immunol (2005) 0.97

Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection. J Immunol (2008) 0.96

Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood (2011) 0.95

Tracing dynamic expansion of human NK-cell subsets by high-resolution analysis of KIR repertoires and cellular differentiation. Eur J Immunol (2014) 0.95

Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection. PLoS One (2011) 0.94

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1. J Infect Dis (2012) 0.94

Processing and degradation of exogenous prion protein by CD11c(+) myeloid dendritic cells in vitro. J Virol (2002) 0.94

Cutting edge: NK cell licensing modulates adhesion to target cells. J Immunol (2013) 0.93

Escape from immune- and nonimmune-mediated tumor surveillance. Semin Cancer Biol (2005) 0.93

Analysis of the KIR repertoire in human NK cells by flow cytometry. Methods Mol Biol (2010) 0.93

Tumor cell recognition by the NK cell activating receptor NKG2D. Eur J Immunol (2008) 0.93

Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response. J Immunol (2013) 0.92